Towards a European personalized registry for colorectal cancer patients: 919 patients have already enrolled!

About the project Download the brochure

What's New?

14M Genomics and EORTC and Announce First Results from their Collaboration on Tumour Profiling

in Media, Press Releases, Science


Cambridge, UK: 16 November 2015. Chaussures Asics Homme tn requin pas cher 14M Genomics (“14MG”) and The European Organisation for Research and Treatment of Cancer (“EORTC”) today announce the delivery of initial genomic mutation analyses conducted on newly diagnosed cancer patients as part of the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) programme…. Read more »

SPECTAforum 2014: Videos available for viewing

in Media


The second edition of SPECTAforum met its objectives with representation of most of the stakeholders. Nike Air Max Dames Goedkoop With SPECTAcolor, Hollister France the first platform, Goedkoop Adidas Schoenen adidas pas cher now rapidly reaching over 200 patients, SPECTA, nike air max 90 homme pas cher an innovative approach to efficient access to molecular… Read more »

EORTC’s SPECTAcolor screening patients with colorectal cancer for efficient clinical trial access

in Media, Published Articles, Science


SPECTAcolor, the EORTC’s premier Screening Platform for Efficient Clinical Trial Access for patients with colorectal cancer, enrolled its 100th patient in February 2014. “We are satisfied with the recruitment of patients with colorectal cancer and the analyses of their tumors. Chaussures Nike Pas Cher air max 1 pas cher Our efforts will lead to the… Read more »

A booklet on Colorectal Cancer Facts and Figures in support of SPECTAcolor!

in Brochure, Media, Science


  A booklet on Colorectal Cancer Facts and Figures including country specific colorectal cancer statistics This booklet is now available for the following Walgreens Boots Alliance fundraising partnering countries: France, nike tn requin Nike Air Max Goedkoop Italy, Spain, cheap nike trainers uk Fjallraven Kanken Occasion The Netherlands, new balance 530 homme soldes Chaussure Adidas… Read more »

1 year in, SPECTAcolor is a viable cancer research model!

in Media


The EORTC is pleased to announce the successful implementation of SPECTAcolor, ‘Screening Patients for Efficient Clinical Trial Access’ – the first Pan European collaborative molecular screening platform for colorectal cancer patients. SPECTAcolor proves the logistical feasibility of the infrastructure that was built to run next generation trials in a multinational setting. Now one year into… Read more »